| Name | Title | Contact Details |
|---|---|---|
Bill Simonet |
VP Sales | Profile |
Maryland Physicians Care is a Windsor Mill, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Aaptiv is a mobile fitness product that is reinventing the way people workout, with audio classes that combine the motivation of a professional trainer with an incredible playlist. From truly fun treadmill workouts to effective elliptical classes, and interval routines that burn major calories, start enjoying your cardio with Aaptiv. Our team is dedicated to the belief that high-quality fitness instruction should not be a privilege for a few, but a right for all. We don`t think of fitness as an end goal, but rather a tool that fuels a richer, more successful life. We are looking for team members who are excited and eager to support our members by building the world`s best audio fitness product!
Aurora Spine Corporation focuses on the development and distribution of spinal implant products for relieving back pain, and preserving spinal bone structure and anatomy in the United States. The company intends to provide interspinous process lumbar fusion devices for patients suffering from degenerative disc disease whose pain has not been eliminated by non-surgical treatment methods; polyether ether ketone interbody cages for use in spinal fusion procedures; and cervical and lumbar devices. It also plans to develop installation tools for surgeons. The company was incorporated in 2013 and is headquartered in Toronto, Canada.
MIDWEST OPTICAL SYSTEMS, INC. is a Palatine, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.